Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease. Backed by SoftBank VF.
About the role
Repertoire is seeking an experienced Senior Accountant to join our growing Finance team, reporting to the Accounting Manager. This role is well suited to an accountant ready to take ownership of key areas of the monthly close, cash reconciliations, accruals, and accounts payable, while working independently across a broad range of responsibilities and serving as a trusted accounting resource across the organization.
What they're looking for
- Assist with the timely completion of the month-end close through the preparation of journal entries, account reconciliations, and period-over-period account fluctuation analyses
- Responsible for the monthly cash reconciliation process
- Maintain fixed asset, lease, and other current asset schedules
- Facilitate the monthly purchase order accrual process, collaborating with external vendors and internal business stakeholders, including FP&A
- Partner with the Accounting Manager to estimate and record monthly material accruals
- Collaborate with outsourced Accounts Payable to resolve vendor and billing issues
More about this role
Company Overview
Repertoire Immune Medicines is a clinical-stage biotechnology company harnessing the power of the human immune system to develop transformative therapies for cancer and autoimmune disease. Using its proprietary DECODE™ platform—which maps the immune synapse between T cell receptors (TCRs) and their antigen targets—Repertoire translates unique biological insights into potent and targeted off-the shelf immune medicines. The company integrates deep protein engineering expertise with artificial intelligence, powered by a proprietary DECODE database of over one billion TCR-antigen interactions, to accelerate discovery and optimize drug candidates.
From its sites in Watertown, Massachusetts and Zurich, Switzerland, Repertoire is advancing a pipeline of T cell-targeted immunotherapies with the potential to address a broad range of cancers and autoimmune disorders. The company’s lead oncology program, RPTR-1-201, a TCR bispecific, has initiated a Phase 1/2 clinical trial across multiple solid tumor indications. Repertoire plans to advance additional TCR bispecific therapies into clinical trials over the next 12-18 months. In autoimmune disease, Repertoire is partnering...
Read the full posting on Repertoire Immune Medicines's site ↗
Browse similar: Startup jobs · Remote jobs